Azzad Asset Management Inc /Adv Recursion Pharmaceuticals, Inc. Transaction History
Azzad Asset Management Inc /Adv
- $386 Billion
- Q4 2024
A detailed history of Azzad Asset Management Inc /Adv transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Azzad Asset Management Inc /Adv holds 14,997 shares of RXRX stock, worth $87,132. This represents 0.03% of its overall portfolio holdings.
Number of Shares
14,997
Previous 14,997
-0.0%
Holding current value
$87,132
Previous $98.8 Million
-0.0%
% of portfolio
0.03%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding RXRX
# of Institutions
341Shares Held
284MCall Options Held
2.83MPut Options Held
3.64M-
Vanguard Group Inc Valley Forge, PA34MShares$198 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$188 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$144 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$101 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$85.2 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.05B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...